Medicine and Health

Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells

D. Candas-green, B. Xie, et al.

This groundbreaking study by Demet Candas-Green, Bowen Xie, and colleagues uncovers the intertwined roles of CD47 and HER2 in driving radioresistance in breast cancer cells. Enhancing expressions of these receptors in irradiated cancer cells reveals a potential treatment avenue through dual receptor blocking, promising a more effective strategy against resilient tumors.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Open Access Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer

Y. Harada, A. Sato, et al.

Medicine and Health

Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression

X. Xia, T. Hu, et al.

Medicine and Health

Invadopodia enable cooperative invasion and metastasis of breast cancer cells

L. Perrin, E. Belova, et al.

Medicine and Health

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial

J. Cortés, S. A. Hurvitz, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny